Replies to post #117504 on Biotech Values

[genisi]

Boehringer/BI 201335

Interim data from phase 2b SILEN-C1. Efficacy ok but AE seems so-so (I mean when you're the 2nd gen you want to be better than the 1st).

http://www.natap.org/2011/EASL/EASL_20.htm